Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

2026 data Public-data reference. official source

Pancreatic Cyst

Open-data reference.

19 US clinical trials · 13 currently recruiting

Active & Recent Trials

RECRUITING 4,000 participants

UCSF PANC Cyst Registry

University of California, San Francis

NCT04291651

RECRUITING 1,368 participants

Pancreas Registry and High Risk Registry

Icahn School of Medicine at Mount Sinai

NCT02775461

RECRUITING 1,174 participants

Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas

H. Lee Moffitt Cancer Center and Research Institute

NCT04275557

RECRUITING 700 participants

A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma

Memorial Sloan Kettering Cancer Center

NCT03334708

RECRUITING 500 participants

Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions

Ohio State University Comprehensive Cancer Center

NCT03492151

RECRUITING 500 participants

Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer

Stanford University

NCT03260842

RECRUITING 310 participants

Artificial Intelligence in Endoscopic Ultrasound

Orlando Health

NCT06564571

RECRUITING NA 300 participants

Evaluation of Pancreatic Cystic Lesions Via EUS-guided Fine Needle Aspiration With and Without Micro Forceps Biopsies

University of Colorado, Denver

NCT04404101

RECRUITING 250 participants

PROMs After Pancreatectomy

University of Arizona

NCT07173257

RECRUITING NA 140 participants

EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope

Orlando Health

NCT06340620

RECRUITING 25 participants

Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms

Memorial Sloan Kettering Cancer Center

NCT06305728

RECRUITING Phase 1 20 participants

Study Using Hyperpolarized 13C-Pyruvate Magnetic Resonance Spectroscopic Imaging in Patients With Pancreatic Cysts Undergoing Surgical Resection

M.D. Anderson Cancer Center

NCT05873699

RECRUITING Phase 1 15 participants

Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection

University of Nebraska

NCT06320990

ACTIVE NOT RECRUITING 317 participants

The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics

H. Lee Moffitt Cancer Center and Research Institute

NCT05692596

ACTIVE NOT RECRUITING 100 participants

Safety and Efficacy of EUS-RFA in the Treatment of Pancreatic Lesions: A Prospective Registry

The University of Texas Health Science Center, Houston

NCT07136324

ACTIVE NOT RECRUITING Phase 3 75 participants

CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts

Milton S. Hershey Medical Center

NCT03085004

COMPLETED 40 participants

Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract

Mauna Kea Technologies

NCT01770405

COMPLETED NA 37 participants

Cyst Fluid Glucose for On-site Diagnosis of Mucinous Pancreatic Cysts

Ochsner Health System

NCT03169842

COMPLETED NA 33 participants

Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts

Indiana University

NCT01643460

Phase Distribution

PhaseTrial count
Early Phase 1 2
Phase 3 1

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Reading the Pancreatic Cyst Trial Landscape

ClinicalTrials.gov lists 19 US studies indexed under Pancreatic Cyst, and 13 of those are currently open to recruitment — roughly 68% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.

The phase distribution for Pancreatic Cyst shows 1 late-stage studies (Phase 3 and Phase 4 combined) alongside 2 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.

Top sponsor activity for Pancreatic Cyst is led by Orlando Health with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 19 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.

Frequently Asked Questions

How many clinical trials are there for Pancreatic Cyst?

PlainTrial tracks 19 US clinical trials for Pancreatic Cyst, of which 13 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Pancreatic Cyst?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →